What is the recommended diagnostic work‑up and initial management for a patient with acute onset fever, headache, altered mental status, seizures, or focal neurologic deficits suggestive of viral encephalitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Viral Encephalitis: Diagnostic Work-Up and Initial Management

Immediate Empiric Treatment

Start intravenous acyclovir 10 mg/kg every 8 hours immediately—within 6 hours of admission—for any patient with suspected encephalitis, even before obtaining lumbar puncture, imaging, or PCR results. 1

  • Delaying acyclovir beyond 48 hours after presentation significantly increases mortality and morbidity 1
  • Early acyclovir reduces HSV encephalitis mortality from >70% to 20–30% 1
  • Do not wait for diagnostic confirmation if it would postpone acyclovir beyond 6 hours 1
  • Continue acyclovir for 14–21 days in confirmed HSV encephalitis 1
  • Adjust dosing in renal impairment 1

Clinical Recognition: When to Suspect Encephalitis

Suspect encephalitis in any patient presenting with fever plus altered mental status (confusion, disorientation, behavioral changes, personality changes) plus any of the following: new seizures, focal neurological signs, or altered consciousness 2

Key Clinical Features by Etiology:

HSV encephalitis (most common treatable cause):

  • Fever (91% of cases), though some present with only low-grade pyrexia 2
  • Disorientation (76%), speech disturbances (59%), behavioral changes (41%) 2
  • Seizures (one-third of patients) 2
  • Temporal lobe involvement on imaging 1

Antibody-mediated encephalitis (critical not to miss):

  • Subacute onset over weeks to months 2
  • Orofacial dyskinesia, choreoathetosis, faciobrachial dystonic seizures 2
  • Intractable seizures often without fever 2
  • Hyponatremia (60% of VGKC-complex cases) 2
  • Profound amnesia and confusion 2

Flavivirus infections (West Nile, Japanese encephalitis):

  • Movement disorders, tremor, basal ganglia signs 1
  • Acute flaccid paralysis 1

Common Pitfalls to Avoid:

  • Behavioral changes can be mistaken for primary psychiatric illness, drug intoxication, or alcohol withdrawal—leading to tragic delays 2, 3
  • Normal Glasgow Coma Score does not exclude encephalitis; it is too crude to detect subtle cognitive changes 2
  • Elderly patients may present atypically, mimicking stroke or systemic sepsis 1

Diagnostic Work-Up Algorithm

Step 1: Immediate Stabilization & Neuroimaging

Before lumbar puncture, many patients require CT to exclude contraindications 2:

  • Obtain urgent CT if: focal neurological signs, papilledema, reduced consciousness (GCS <12), new-onset seizures, or immunocompromised status 2
  • MRI is strongly preferred over CT when feasible—detects early changes in ~90% of cases versus only 25% for CT 4
  • MRI should be obtained within 48 hours 4

Step 2: Lumbar Puncture & CSF Analysis

Perform lumbar puncture as soon as possible after admission unless contraindicated 1:

Essential CSF studies 1:

  • Opening pressure
  • Cell count with differential
  • Protein and glucose (with paired serum glucose)
  • HSV-1/2 PCR (most critical test)
  • Varicella-zoster virus (VZV) PCR
  • Enterovirus PCR
  • West Nile virus serology/PCR (if epidemiologically relevant)
  • Bacterial culture and Gram stain
  • Consider: CMV PCR, EBV PCR, HHV-6 PCR (especially in immunocompromised)
  • Consider: paired oligoclonal bands
  • Lactate

If initial HSV PCR not sent or negative but suspicion remains high: Repeat lumbar puncture at 24 hours and send second HSV PCR 2

Critical caveat for immunocompromised patients: CSF may be acellular despite active CNS infection—still obtain full microbiological panel regardless of cell count 2, 1

Step 3: Serum Studies

All patients should have serum tested for 2:

  • VGKC-complex antibodies
  • NMDA-receptor antibodies
  • Basic metabolic panel (check sodium—hyponatremia suggests antibody-mediated encephalitis) 2

Additional serum tests based on exposure history 4:

  • Malaria rapid antigen and thick/thin blood films (three sets) if travel to endemic area
  • Arbovirus serology if appropriate exposure
  • HIV testing
  • Toxoplasma serology if immunocompromised

Step 4: Electroencephalography (EEG)

  • EEG is abnormal in >80% of encephalitis cases 4
  • Obtain EEG when: distinguishing organic from psychiatric causes, or when subtle motor activity or non-convulsive seizures suspected 4
  • Periodic lateralized epileptiform discharges (PLEDs) may appear in HSV but are not specific 1

Step 5: Consider Brain Biopsy (Rarely)

Brain biopsy is not indicated during initial assessment 1

Consider stereotactic biopsy after the first week only if 1:

  • No diagnosis despite comprehensive work-up
  • Focal imaging abnormalities present
  • Patient deteriorates despite empiric therapy
  • HSV PCR negative but clinical suspicion remains very high

Etiology-Specific Treatment Modifications

HSV Encephalitis (Confirmed)

  • Acyclovir 10 mg/kg IV every 8 hours for 14–21 days 1
  • In immunocompromised: extend to at least 21 days, repeat CSF PCR to confirm clearance, consider long-term oral suppressive therapy 1

VZV Encephalitis

  • Acyclovir 10–15 mg/kg IV three times daily 1
  • Consider short course of corticosteroids if vasculitic component suspected 1

VGKC-Complex Autoimmune Encephalitis

  • High-dose oral corticosteroids (0.5 mg/kg/day) for 3–6 months, then taper over 12 months 2
  • If acutely unwell: add IV immunoglobulin (0.4 g/kg/day) or plasma exchange to accelerate improvement 2
  • Screen for underlying malignancy (thymoma, small-cell lung cancer in <10%) 2

NMDAR Encephalitis

  • Remove underlying tumor when present—improves outcomes 2
  • High-dose corticosteroids as first-line 4
  • Alternatives: plasma exchange or IV immunoglobulin 4

Acute Disseminated Encephalomyelitis (ADEM)

  • High-dose corticosteroids first-line 4
  • Alternatives: plasma exchange or IV immunoglobulin 4

Cerebral Malaria (Plasmodium falciparum)

  • Quinine, quinidine, or artemether 4
  • Exchange transfusion if ≥10% parasitemia 4
  • Do not use corticosteroids 4

Toxoplasma Encephalitis

  • Pyrimethamine plus either sulfadiazine or clindamycin 4

Special Populations

Immunocompromised Patients

  • Manage HIV-positive patients in specialized HIV centers 2
  • Broader differential includes: HHV-6, CMV, EBV, toxoplasmosis, cryptococcus, tuberculosis, listeriosis 1
  • Obtain CT before lumbar puncture given higher risk of mass lesions 1
  • Presentations may be atypical with prolonged subtle symptoms, absent fever, or normal CSF white-cell count 1

Returning Travelers

  • Consider region-specific pathogens: Japanese encephalitis, West Nile virus, tick-borne encephalitis, cerebral malaria, African trypanosomiasis 1
  • Involve tropical medicine specialists for targeted testing 1

Critical Care & Supportive Management

Patients with falling level of consciousness require urgent ICU assessment for 4:

  • Airway protection and ventilatory support
  • Management of raised intracranial pressure
  • Optimization of cerebral perfusion pressure
  • Correction of electrolyte imbalances (especially hyponatremia)

Disposition & Follow-Up

  • Manage patients in settings where neurological specialist review is available within 24 hours 4
  • Appropriate settings include: neurological wards, high-dependency units, or ICU depending on severity 4
  • Do not discharge without a definite or suspected diagnosis 4
  • Formulate discharge plans including outpatient follow-up, ongoing therapy, and rehabilitation 4
  • All patients require access to rehabilitation assessment—sequelae may not be immediately apparent at discharge 4

References

Guideline

Key Evidence‑Based Recommendations for Suspected Encephalitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Limbic Encephalitis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Acute Encephalitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.